Expanding access to lifesaving commodities
How PATH is improving access to lifesaving commodities like oxygen and contraception, essential for reducing preventable deaths and improving health outcomes globally
From vaccines and diagnostics to medical devices and digital tools, PATH develops and scales up health products that address local priorities and improve access. Still, fit-for-purpose health products only work if the people who need them can access them. That’s why we work in partnership with governments, civil society, and the private sector to mobilize resources and create effective markets and regulatory systems that can bring these lifesaving solutions to scale.
Our advocacy and policy experts are committed to improving access to lifesaving commodities to reduce preventable deaths and improve health outcomes globally. For example, oxygen therapy plays a critical role in saving the lives of newborns, children, and adults, and PATH continues to drive efforts to secure financing and advocate for policies that prioritize access to medical oxygen. Additionally, PATH is supporting the widespread use of Subcutaneous DMPA (DMPA-SC). This innovative and easy-to-administer injectable contraceptive is transforming access to family planning for women and adolescent girls.
By advancing both oxygen access and contraceptive choice, PATH is helping to shape policies and funding strategies that ensure critical health services are available to all.
PATH's Injectables Access Collaborative (AC) provides data-driven technical assistance, coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming.
This primer provides the data, messages, and resources to help understand the planning, policies, and technologies involved in oxygen delivery scale-up. The materials are useful to anyone who wants to learn about scaling up access to oxygen and integrating oxygen delivery across national and subnational policies, programs, and health budgets.
This factsheet explains how PATH advocates collect, analyze, package, and use data to inform policies, mobilize resources, engage citizens, and hold decision-makers accountable across all levels to help women and children around the world survive and thrive.
The Injectable Access Collaborative’s DMPA-SC Advocacy Pack is designed to accelerate your advocacy efforts. It consists of evidence-based materials for advocates to use both for their own strategy development and for direct advocacy with decision-makers.
PATH’s Asset Tracker explores the status of scale-up of key evidence-based interventions that improve health for moms and kids.
